The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold

Biomaterials

Volumn 29, Issue 11, 2008, Pages 1620-1629

  Scuderi, Nicolò ^a   Onesti, Maria G ^a   Bistoni, Giovanni ^a   Ceccarelli, Simona ^a   Rotolo, Sabrina ^a   Angeloni, Antonio ^a   Marchese, Cinzia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autologous cell; Co culture; Hyaluronic acid scaffold; Transplantation

Indexed keywords

CORRELATION METHODS; FIBROBLASTS; HOSPITALS; SURGERY;

AUTOLOGOUS CELLS; HYALURONIC ACID; KERATINOCYTES; MELANOCYTES; SKIN BIOPSY;

SKIN;

B RAF KINASE; HYALURONIC ACID;

ARTICLE; BIOENGINEERING; CANCER RISK; CASE REPORT; CELL CULTURE; CELL POLARITY; CELL TRANSFORMATION; CELL TRANSPLANTATION; COCULTURE; DERMIS; EPIDERMIS; EPITHELIZATION; FEMALE; FIBROBLAST; GENETIC ASSOCIATION; GIANT PIGMENTED NEVUS; HISTOLOGY; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MATRIX ATTACHMENT REGION; MELANOCYTE; MELANOMA; NEVUS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCAR FORMATION; SCHOOL CHILD; SKIN BIOPSY; SKIN GRAFT; SURGICAL APPROACH;

BASE SEQUENCE; BIOARTIFICIAL ORGANS; BIOMEDICAL ENGINEERING; BIOPSY; CELLS, CULTURED; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; FEMALE; FIBROBLASTS; GENE DELETION; HUMANS; HYALURONIC ACID; KERATINOCYTES; MELANOCYTES; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; SKIN DISEASES; SKIN TRANSPLANTATION; TISSUE CULTURE TECHNIQUES; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS;

EID: 38749136979     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.12.024     Document Type: Article

References (39)

1. Boyce S.T., Kagan R.J., Meyer N.A., Yakuboff K.P., and Warden G.D. The 1999 clinical research award. Cultured skin substitutes combined with integra artificial skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. J Burn Care Rehabil 20 (1999) 453-461
2. Boyce S.T., Kagan R.J., Yakuboff K.P., Meyer N.A., Rieman M.T., Greenhalgh D.G., et al. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg 235 (2002) 269-279
3. Quaba A.A., and Wallace A.F. The incidence of malignant melanoma (0 to 15 years of age) arising in "large" congenital nevocellular nevi. Plast Reconstr Surg 78 (1986) 174-181
4. Ruiz-Maldonado R., Tamayo L., Laterza A.M., and Duran C. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr 120 (1992) 906-911
5. Marghoob A.A., Schoenbach S.P., Kopf A.W., Orlow S.J., Nossa R., and Bart R.S. Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study. Arch Dermatol 132 (1996) 170-175
6. Kaplan E.N. The risk of malignancy in large congenital nevi. Plast Reconstr Surg 53 (1974) 421-428
7. Sober A.J., and Burstein J.M. Precursors to skin cancer. Cancer 75 (1995) 645-650
8. Tannous Z.S., Mihm Jr. M.C., Sober A.J., and Duncan L.M. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol 52 (2005) 197-203
9. Rhodes A.R., Wood W.C., Sober A.J., and Mihm Jr. M.C. Nonepidermal origin of malignant melanoma associated with giant congenital nevocellular nevus. Plast Reconstr Surg 67 (1981) 782-790
10. Arons M.S., and Hurwitz S. Congenital nevocellular nevus: a review of the treatment controversy and a report of 46 cases. Plast Reconstr Surg 72 (1983) 355-365
11. Davies H., Bignell G.R., Cox C., Shephens P., Edkins S., Clegg S., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
12. Flores J.F., Walker G.J., Glendening J.M., Haluska F.G., Castresana J.S., Rubio M.P., et al. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res 56 (1996) 5023-5032
13. Walker G.J., Flores J.F., Glendening J.M., Lin A.H., Markl I.D., and Fountain J.W. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer 22 (1998) 157-163
14. Pollock P.M., Harper U.L., Hansen K.S., Yudt L.M., Stark M., Robbins C.M., et al. High frequency of BRAF mutations in nevi. Nat Genet 33 (2003) 19-20
15. Sharpless N.E., Ramsey M.R., Balasubramanian P., Castrillon D.H., and DePinho R.A. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 23 (2004) 379-385
16. Fargnoli M.C., Chimenti S., Keller G., Soyer H.P., Dal Pozzo V., Hofler H., et al. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. J Invest Dermatol 111 (1998) 1202-1206
17. Campoccia D., Doherty P., Radice M., Brun P., Abatangelo G., and Williams D.F. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 19 (1998) 2101-2127
18. Zacchi V., Soranzo C., Cortivo R., Radice M., Brun P., and Abatangelo G. In vitro engineering of human skin-like tissue. J Biomed Mater Res 40 (1998) 187-194
19. Galassi G., Brun P., Radice M., Cortivo R., Zanon G.F., Genovese P., et al. In vitro reconstructed dermis implanted in human wounds: degradation studies of the HA-based supporting scaffold. Biomaterials 21 (2000) 2183-2191
20. Stark H.J., Willhauck M.J., Mirancea N., Boehnke K., Nord I., Breitkreutz D., et al. Authentic fibroblast matrix in dermal equivalents normalises epidermal histogenesis and dermoepidermal junction in organotypic co-culture. Eur J Cell Biol 83 (2004) 631-645
21. Earle S.A., and Marshall D.M. Management of giant congenital nevi with artificial skin substitutes in children. J Craniofac Surg 16 (2005) 904-907
22. Pellegrini G., Ranno R., Stracuzzi G., Bondanza S., Guerra L., and Zambruno G. The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 68 (1999) 868-879
23. Ronfard V., Rives J.M., Neveux Y., Carsin H., and Barrandon Y. Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation 70 (2000) 1588-1598
24. Aigner J., Tegeler J., Hutzler P., Campoccia D., Pavesio A., Hammer C., et al. Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res 42 (1998) 172-181
25. Brun P., Abatangelo G., Radice M., Zacchi V., Guidolin D., Daga Gordini D., et al. Chondrocyte aggregation and reorganization into three-dimensional scaffolds. J Biomed Mater Res 46 (1999) 337-346
26. Benedetti L., Cortivo R., Berti T., Berti A., Pea F., Mazzo M., et al. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomaterials 14 (1993) 1154-1160
27. Cortivo R., Brun P., Rastrelli A., and Abatangelo G. In vitro studies on biocompatibility of hyaluronic acid esters. Biomaterials 12 (1991) 727-730
28. Stark H.J., Szabowski A., Fusenig N.E., and Maas-Szabowski N. Organotypic cocultures as skin equivalents: a complex and sophisticated in vitro system. Biol Proced Online 6 (2004) 55-60
29. Radice M., Brun P., Cortivo R., Scapinelli R., Battaliard C., and Abatangelo G. Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res 50 (2000) 101-109
30. Myers S.R., Grady J., Soranzo C., Sanders R., Green C., Leigh I.M., et al. A hyaluronic acid membrane delivery system for cultured keratinocytes: clinical 'take' rates in the porcine kerato-dermal model. J Burn Care Rehabil 18 (1997) 214-222
31. Donati L., Veronesi A.M., Garbin S., Ordanini M.N., Ferrone M.P., Falcone L., et al. In vitro development and clinical application in burn patients of keratinocytes cultured on a hyaluronic acid ester membrane. In: Williams D.F. (Ed). Novel biomaterials based on hyaluronic acid and its derivatives. Proceedings of a workshop held at the annual meeting of the European society for biomaterials (1994) 52-61 Pisa, Italy
32. Donati L., Marazzi M., Veronesi A.M., Ordanini M.N., Falcone L., Ferrone M., et al. Treatment of cutaneous wound with cultured human keratinocytes on hyaluronic acid membrane. Wound Repair Regen 3 (1995) 363
33. Solchaga L.A., Dennis J.E., Goldberg V.M., and Caplan A.I. Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage. J Orthop Res 17 (1999) 205-213
34. Bello Y.M., Falabella A.F., and Eaglstein W.H. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2 (2001) 305-313
35. Liu Y., Suwa F., Wang X., Takemura A., Fang Y.R., Li Y., et al. Reconstruction of a tissue-engineered skin containing melanocytes. Cell Biol Int 31 (2007) 985-990
36. Simonetti O., Hoogstraate A.J., Bialik W., Kempenaar J.A., Schrijvers A.H., Boddè H.E., et al. Visualization of diffusion pathways across the stratum corneum of native and in-vitro-reconstructed epidermis by confocal laser scanning microscopy. Arch Dermatol Res 287 (1995) 465-473
37. Rudolph R. The effect of skin graft preparation on wound contraction. Surg Gynecol Obstet 142 (1976) 49-56
38. Supp D.M., Wilson-Landy K., and Boyce S.T. Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice. FASEB J 16 (2002) 797-804
39. Tonello C., Vindigni V., Zavan B., Abatangelo S., Abatangelo G., Brun P., et al. In vitro reconstruction of an endothelialized skin substitute provided with a microcapillary network using biopolymer scaffolds. FASEB J 19 (2005) 1546-1548